Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;110(4):1353-1358.
doi: 10.1111/apa.15643. Epub 2020 Nov 18.

Comorbidity of inflammatory bowel disease in children and adolescents with type 1 diabetes

Affiliations

Comorbidity of inflammatory bowel disease in children and adolescents with type 1 diabetes

Hildegard Jasser-Nitsche et al. Acta Paediatr. 2021 Apr.

Abstract

Aim: To determine the prevalence of inflammatory bowel disease (IBD) in patients with type 1 diabetes (T1D) and to characterise patients with both diseases.

Methods: Data of 65.147 patients with T1D ≤18 years of 379 centres in Germany and Austria participating in the DPV initiative were analysed. A total of 63 children had comorbid IBD; IBD prevalence was 0.1%. Regression models were used to analyse differences in metabolic control, acute complications and steroid intake.

Results: Mean BMI-SDS in patients with T1D and IBD was lower (-0.15 ± 0.11) compared to patients with T1D only (0.27 ± 0.00, p < .001). Patients with T1D and IBD had a significantly higher use of steroids (22% ± 0.05% vs. 1% ± 0.00, p < .001) and a significantly higher rate of severe hypoglycaemic events per patient year (0.33 ± 0.07 vs. 0.16 ± 0.00, p = .001). No differences were found in HbA1c levels, insulin dose and occurrence of DKA.

Conclusion: Although children and adolescents with T1D and IBD take steroids more often, they suffer from severe hypoglycaemia more frequently and have a lower BMI-SDS. These findings might be explained by chronic intestinal inflammation leading to malabsorption, malnutrition and increased severe hypoglycaemia.

Keywords: children; hypoglycaemia; inflammatory bowel disease; prevalence; type 1 diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Selection of patients
FIGURE 2
FIGURE 2
Acute complications (adjusted for age, sex and diabetes duration)

References

    1. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383:69‐82. - PMC - PubMed
    1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on a systematic review. Gastroenterology. 2012;142:46‐54.e42. - PubMed
    1. Lopez RN, Evans HM, Appleton L, et al. Prospective incidence of paediatric inflammatory bowel disease in New Zealand in 2015: results from the paediatric inflammatory bowel disease in New Zealand (PINZ) study. J Pediatric Gastroenterol Nutr. 2018;66:e122‐e126. - PubMed
    1. Schober E, Waldhoer T, Rami B, Hofer S, Austrian Diabetes Incidence Study Group . Incidence and time trend of type 1 and type 2 diabetes in Austrian children 1999–2007. J Pediatr. 2009;155:190‐193.e1. - PubMed
    1. Ehehalt S, Dietz K, Willasch AM, Neu A. Prediction model for the incidence and prevalence of type 1 diabetes in childhood and adolescence: evidence for a cohort‐dependent increase within the next two decades in Germany. Pediatr Diabetes. 2012;13:15‐20. - PubMed

Substances